1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Eli Lilly Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
1058.56 49.04 (4.86%)
69.70% Gain from 52W Low
4.8M
XNYS Volume

XNYS 23 Feb, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Eli Lilly is on 02 Mar 2026 for the purpose of TD Cowen 46th Annual Health Care Conference See details
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
31.0 / 100
Momentum Score
Technically Moderately Bullish
62.2 / 100
Turnaround Potential These stocks have average financials and valuation, but strong momentum indicating buying interest View Similar Embed DVM
Analyst Price Target
1,213
1Yr Price target upside is 15%
28 analysts

23

S

6

W

5

O

1

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..